Drinking six cups of coffee a day could leave a man pretty wired, but it may also help lower his risk of fatal prostate cancer, according to a new study from the Harvard School of Public Health.
prostate cancer
Good News, Guys: Spikes in PSA Don’t Mean Prostate Cancer
The National Comprehensive Cancer Network and the American Urological Association currently recommend that men who have a spike in prostate specific antigen (PSA) levels get a biopsy to test for prostate cancer — even if their …
How Early Balding Is Linked to Prostate Cancer
No man looks forward to the first signs of balding — especially early in life — but now there’s fresh evidence that losing your hair may be a harbinger of a more serious health concern and worth tracking for reasons other …
Could Pomegranates Help Stop Cancer Cells?
POM Wonderful, maker of pomegranate juice and other pomegranate-containing products, ran afoul of the Food and Drug Administration and Federal Trade Commission in September for making “false and unsubstantiated” health claims on …
FTC and FDA to POM: You’re Not So Wonderful
Pomegranates may be full of healthful antioxidants, but there’s no evidence that POM Wonderful’s pomegranate products prevent heart disease, prostate cancer or erectile dysfunction, according to the U.S. government.
The BPA Debate: Bad Reputation and Still No Answers
Bisphenol-A (BPA), the endocrine-disrupting chemical in plastics — and the go-to environmental health villain — has vexed public-health experts for at least a decade. Reams of inconclusive and conflicting studies on the …
A Blood Test for Cancer?
Any cancer doctor will tell you that the earlier you pick up a tumor, the better your chances are of treating it and getting it under control.
So researchers at the annual meeting of the American Society of Clinical Oncology in Chicago are announcing some welcome news on that front. Scientists at the biotechnology company Chronix …
FDA approves novel prostate cancer “vaccine”
The U.S. Food and Drug Administration approved a new prostate cancer treatment Thursday. The treatment, which works by turning the body’s immune system against invading cancer cells, is called Provenge and is manufactured by Seattle biotech firm Dendreon. According to a story that ran on the front page of the Seattle Times this past
…
In high-risk men, drug may help prevent prostate cancer
A four-year study of more than 8,000 men between the ages of 50 to 75 who had an elevated risk for developing prostate cancer found that those who took the drug dutasteride (sold as Avodart) were less likely to develop prostate cancer than those taking a placebo. What’s more, study participants taking dutasteride were significantly less
…
Regular prostate cancer screening still not advised
The American Cancer Society released updated prostate cancer screening recommendations yesterday that largely reiterate existing guidance—advising men to discuss the issue with their physicians and make a decision about the potential benefits of screening based on their individual medical histories and age. The new recommendations
…